254 related articles for article (PubMed ID: 15318323)
1. Chemoprevention of breast cancer.
Zelnak AB; O'Regan RM
Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
[No Abstract] [Full Text] [Related]
2. Breast Cancer Risk-Reducing Medications.
Graham D; DiNome ML; Ganz PA
JAMA; 2020 Jul; 324(3):310. PubMed ID: 32692388
[No Abstract] [Full Text] [Related]
3. Chemoprevention of breast cancer: recommendations and rationale.
U.S. Preventive Services Task Force
Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
[No Abstract] [Full Text] [Related]
4. Breast cancer prevention in high-risk women: searching for new options.
Nelson NJ
J Natl Cancer Inst; 2011 May; 103(9):710-1. PubMed ID: 21515834
[No Abstract] [Full Text] [Related]
5. Medications for Primary Prevention of Breast Cancer.
Shieh Y; Tice JA
JAMA; 2020 Jul; 324(3):291-292. PubMed ID: 32692377
[No Abstract] [Full Text] [Related]
6. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
[TBL] [Abstract][Full Text] [Related]
7. An update on breast cancer prevention trials.
Wickerham DL; Fourchotte V
Int J Gynecol Cancer; 2006; 16 Suppl 2():498-501. PubMed ID: 17010056
[TBL] [Abstract][Full Text] [Related]
8. STAR: first-year recruitment efforts set brisk pace for future.
CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236
[No Abstract] [Full Text] [Related]
9. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
Vogel VG
Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.
Ann Intern Med; 2002 Jul; 137(1):I62. PubMed ID: 12093267
[No Abstract] [Full Text] [Related]
11. Breast cancer chemoprevention: current status and future directions.
Wickerham DL; Tan-Chiu E
Semin Oncol; 2001 Jun; 28(3):253-9. PubMed ID: 11402435
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of women into trials.
Benson JR
Lancet; 2002 Jan; 359(9301):164. PubMed ID: 11809281
[No Abstract] [Full Text] [Related]
13. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.
Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ
Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916
[TBL] [Abstract][Full Text] [Related]
14. Prevention of breast cancer using SERMs and aromatase inhibitors.
Strassmer-Weippl K; Goss PE
J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):5-18. PubMed ID: 14587860
[TBL] [Abstract][Full Text] [Related]
15. Role of antiestrogens and aromatase inhibitors in breast cancer treatment.
Bentrem DJ; Jordan VC
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):5-12. PubMed ID: 11801870
[TBL] [Abstract][Full Text] [Related]
16. Upstaging tamoxifen? New classes of drugs emerging for breast cancer.
Twombly R
J Natl Cancer Inst; 2002 Apr; 94(7):474-5. PubMed ID: 11929942
[No Abstract] [Full Text] [Related]
17. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
[TBL] [Abstract][Full Text] [Related]
18. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
Ricart JJ
Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
[TBL] [Abstract][Full Text] [Related]
19. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
Fabian CJ; Kimler BF
Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
[TBL] [Abstract][Full Text] [Related]
20. Preventive therapy for breast cancer: a consensus statement.
Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H
Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
